IRWD
IRONWOOD PHARMACEUTICALS INCPrice
Daily candles with volume. Callouts mark insider and congressional trades, rating changes, 13F stakes, reports, catalysts, court and regulator actions, Reddit spikes and short-interest jumps. Hover one for the details (tap on phones).
- Jan 5 ▲ Citizens upgrades
- Feb 23 to Feb 24 ▼ 2 days of insider sells: $958.0K by 3 insiders, avg $3.73
- Feb 23 ▼ Six open-market share sales by three C-suite executives at Ironwood…
- Feb 23 ▼ Ironwood Pharmaceuticals CEO Thomas McCourt and CFO Gregory Martini…
- Mar 17 ▼ 1 insider sell $20.5M at $3.05
- May 7 ▲ Ironwood Pharmaceuticals reported a massive Q1 2026 beat with GAAP E…
- May 13 IRWD CFO Gregory Martini resigned effective May 15, 2026, with Ronal…
- Jun 16 ▼ 1 insider sell $80.5K at $3.73
- Jul 7 ▼ 1 insider sell $578.1K at $4.52
- Aug 6 ▲ Ironwood Pharmaceuticals reported Q2 2026 GAAP EPS of $0.31, beating…
- Nov 5 ▲ Ironwood Pharmaceuticals reported Q3 2026 total revenue of $133.0M (…
- Nov 5 ▲ Earnings: IRWD Q3 2026 Earnings: EPS $0.36 (+9.2% vs est)
Signal stack
Where each data set points today.
- InsidersBEARISH
6 insiders sold $22.1M.
- InstitutionsBULLISH
Q3 2026: 24 added (0 new), 12 trimmed or exited.
- EstimatesFLAT
Current-quarter EPS estimate $0.393 → $0.390 over 90 days. 1 up, 0 down in 30 days.
- Short sellersSTEADY
Short interest −6.5% to 14.86M shares. 9.8 days to cover, ≈9.0% of shares.
- TrendUPTREND
22% above its 50-day average.
- SocialQUIET
No Reddit mentions this week. Last mention Nov 6.
Who's buying
13F· Q3 2026| Fund | Move | Value |
|---|---|---|
| MARSHALL WACE, LLP | TRIM | $10.2M |
| O'SHAUGHNESSY ASSET MANAGEMENT, LLC | DOUBLED | $5.2M |
| FMR LLC | ADD | $5.0M |
| FRANKLIN TEMPLETON INC | ADD | $4.8M |
| HRT FINANCIAL LP | ADD | $4.3M |
| Qube Research & Technologies Ltd | DOUBLED | $3.4M |
| Nuveen, LLC | ADD | $1.9M |
| PRINCIPAL FINANCIAL GROUP INC | DOUBLED | $1.3M |
Quarterly 13F filings are due 45 days after each quarter ends.
The Street
Last action Feb 2026Price is inside the target range. Median implies +13%.Targets as of Nov 17, 2026.
| Date | Firm | Rating |
|---|---|---|
| Feb 26, 2026 | Citizens MAINTAIN | Market Outperform |
| Jan 5, 2026 | Wells Fargo MAINTAIN | Equal-Weight |
| Jan 5, 2026 | Citizens UPGRADE | Market Outperform |
| Nov 11, 2025 | Wells Fargo MAINTAIN | Equal-Weight |
| Apr 15, 2025 | Wells Fargo DOWNGRADE | Equal-Weight |
| Apr 15, 2025 | Jefferies DOWNGRADE | Hold |
Insider ledger
Form 4| Insider | Type | Value |
|---|---|---|
DENNER ALEXANDER J Director Sep 15, 2026 | AWARD | 3,694 sh |
Silber Jeffrey SVP, CMO, Head-Res&Drug Jul 20, 2026 | AWARD | 137,036 sh |
Silver Ronald PFO & PAO Jul 7, 2026 | SELL | $578.1K |
Duane Jon R Director Jun 16, 2026 | AWARD | 63,481 sh |
Kessler Marla L Director Jun 16, 2026 | AWARD | 63,481 sh |
Moukheibir Catherine Director Jun 16, 2026 | AWARD | 63,481 sh |
Currie Mark G Director Jun 16, 2026 | AWARD | 63,481 sh |
Shepard Jay Director Jun 16, 2026 | AWARD | 63,481 sh |
Earnings setup
Estimates| Period | EPS est. | Range | 30D rev. | Revenue |
|---|---|---|---|---|
| Current Q | $0.39 | $0.37–$0.41 | +14.7% | $136.2M |
| Next Q | $0.30 | $0.26–$0.35 | +3.4% | $108.9M |
| Current FY | 🔒 Fresh data, subscribers only | |||
| Next FY | $1.57 | $1.36–$1.82 | +4.4% | $504.2M |
Short side
FINRA· Oct 30, 2026SecBot reports
13 filings · 3 bullish · 3 bearish · 1 mixed · 6 neutral- NEUTRAL SC 13G/ANov 16, 2026
Armistice Capital LLC filed an amended Schedule 13G disclosing a passive 9.08% stake (15,000,000 shares) in Ironwood Pharmaceuticals as of September 30, 2026. This is a new passive disclosure for Armistice Capital; no prior 13G from this filer was in the provided context.
🔒 Fresh report (last 24h), subscribers only
- NEUTRAL 144Nov 13, 2026
Tammi Gaskins, an officer of Ironwood Pharmaceuticals, filed a Form 144 notice of intent to sell…
This is a routine tax-withholding sale by an officer, not a discretionary insider sale. It does not signal a change in management's view of the company. Monitor future Form 4 filings for any…
- NEUTRAL SC 13GNov 10, 2026
State Street Corp filed a Schedule 13G disclosing a passive 4.1% stake (6,723,774 shares) in…
The increase in institutional ownership from a major custodian bank is a routine passive filing. Monitor for any future 13D conversion if State Street's activity pattern changes, but no near-term…
- NEUTRAL INST-CLUSTERNov 9, 2026
Eight institutional buyers accumulated $3.0M in new IRWD positions during Q3 2026, while two…
The cluster shows divergent institutional views: small asset managers are accumulating while two large holders (Citigroup, Deutsche Bank) are significantly reducing. The net selling suggests caution…
All IRWD filing & press-release reports (13)
- SC 13G/A reportNov 16, 2026
- 144 reportNov 13, 2026
- SC 13G reportNov 10, 2026
- INST-CLUSTER reportNov 9, 2026
- 8-K reportNov 5, 2026
- SC 13G/A reportOct 28, 2026
- 8-K reportOct 16, 2026
- 8-K reportAug 6, 2026
- 8-K reportMay 13, 2026
- 8-K reportMay 7, 2026
- CLUSTER reportFeb 23, 2026
- CLUSTER reportFeb 23, 2026
- 8-K reportFeb 25, 2026